Lithium Versus Lamotrigine in Bipolar Disorder, Type II
ConditionBipolar II Disorder
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity Hospital Bispebjerg and Frederiksberg
About this trial
The investigators want in a 6-month randomized controlled trial (RCT) to compare effects of lithium versus lamotrigine on mood stabilization and other critical patient outcomes in patients with BDII.
Eligibility criteria
Qualifiers
Bipolar disorder, type II with diagnosis confirmed by SCAN interview
Age 18-70 years
Habile (i.e., able to give informed consent)
Disqualifiers
Past non-response or intolerance to lamotrigine or lithium with > 6 weeks treatment at an adequate dosage
Currently taking mood stabilizers at enrollment in CADIC
Severe chronic kidney disease
Severe cardiac insufficiency
Trial design
Treatments tested in this trial
- Lithium Carbonate
- Lamotrigine
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov